Balchem Corporation will host a conference call on October 21, 2025, to discuss third quarter financial results.
Quiver AI Summary
Balchem Corporation will hold a conference call on October 21, 2025, at 11:00 AM ET to discuss its third quarter 2025 financial results, which will be released that morning before the market opens. The call will be led by Chairman and CEO Ted Harris and CFO Martin Bengtsson. Interested parties can join the call via phone or listen to a live webcast on the company’s website. A replay will be available for one year after the event. Balchem produces specialty ingredients that enhance health and well-being across various industries, operating in three key segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Potential Positives
- Announcement of a conference call to review third quarter 2025 results, demonstrating transparency and commitment to keeping investors informed.
- Involvement of the Chairman, President, and CEO, along with the CFO, in the call indicates a strong leadership presence and engagement with the financial community.
- Availability of financial results and supporting documents on the company website prior to the call enhances accessibility and transparency for investors and analysts.
Potential Negatives
- The press release does not provide any information regarding the actual financial performance expected for the third quarter, which may lead to speculation and uncertainty among investors.
- There is no mention of any recent achievements or positive developments that could enhance investor confidence, potentially signaling a lack of progress or issues within the company.
- The reliance on a future conference call to communicate financial results may imply that current sentiment around the company's performance is weak or unclear, which could negatively affect stock prices leading up to the announcement.
FAQ
When is Balchem's third quarter 2025 conference call?
Balchem's third quarter 2025 conference call is scheduled for Tuesday, October 21, 2025, at 11:00 AM ET.
How can I join Balchem's earnings call?
You can join the call by dialing 800-715-9871 (toll free USA/Canada) or +1-646-307-1963 (USA/International).
Where can I find Balchem's third quarter financial results?
The third quarter results will be published before market opening on Balchem's website on October 21, 2025.
Is there a webcast available for Balchem's conference call?
Yes, the conference call will be available for live streaming at https://events.q4inc.com/attendee/857727932.
Who are the key speakers for the conference call?
Ted Harris, Chairman and CEO, and Martin Bengtsson, CFO, will host the conference call.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BCPC Congressional Stock Trading
Members of Congress have traded $BCPC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BCPC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 04/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BCPC Hedge Fund Activity
We have seen 205 institutional investors add shares of $BCPC stock to their portfolio, and 152 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- APG ASSET MANAGEMENT N.V. removed 917,284 shares (-79.4%) from their portfolio in Q2 2025, for an estimated $146,031,612
- BLACKROCK, INC. removed 112,431 shares (-2.2%) from their portfolio in Q2 2025, for an estimated $17,899,015
- WASATCH ADVISORS LP removed 108,916 shares (-10.2%) from their portfolio in Q2 2025, for an estimated $17,339,427
- PITCAIRN CO added 102,013 shares (+3083.8%) to their portfolio in Q2 2025, for an estimated $16,240,469
- GOLDMAN SACHS GROUP INC removed 97,749 shares (-39.6%) from their portfolio in Q2 2025, for an estimated $15,561,640
- TWO SIGMA INVESTMENTS, LP added 97,448 shares (+158.4%) to their portfolio in Q2 2025, for an estimated $15,513,721
- QUBE RESEARCH & TECHNOLOGIES LTD added 94,148 shares (+66.0%) to their portfolio in Q2 2025, for an estimated $14,988,361
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BCPC Analyst Ratings
Wall Street analysts have issued reports on $BCPC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 04/28/2025
To track analyst ratings and price targets for $BCPC, check out Quiver Quantitative's $BCPC forecast page.
Full Release
MONTVALE, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Tuesday, October 21, 2025, at 11:00 AM Eastern Time (ET) to review third quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call.
Third quarter results will be published prior to the market opening on Tuesday, October 21, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com , prior to the conference call.
Institutional investors, analysts and other members of the financial community are invited to join the live call by dialing 800-715-9871 (toll free USA/Canada), +1-646-307-1963 (USA/International) or 647-932-3411 (Canada/Toronto), five minutes prior to the scheduled start time of the conference call. Investors and the public are invited to listen to the live webcast at https://events.q4inc.com/attendee/857727932 . The conference call will be available for replay shortly after the conclusion of the call at https://events.q4inc.com/attendee/857727932 for one year.
About Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement, and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
| Contact: |
Jacqueline Yarmolowicz, Executive Assistant
Telephone: 845-326-5600 E-mail: [email protected] |
|
